People

David Perlman
David C. Perlman, MD
CDUHR - Director, Infectious Disease Epidemiology and Social-behavioral Theory Core
Mount Sinai Health System - Professor of Medicine, Icahn School of Medicine
Email: david.perlman@mountsinai.org
Education
MD, Medicine, Albert Einstein College of Medicine
BA. Biochemistry & Anthropology, Dartmouth College
Research Interests
HIV, HCV, IDUs, Diagnosis and treatment
BIO
David Perlman has over 20 years’ experience in HIV, HCV, TB and STIs and remains active as a clinician in these areas. He has served as principal investigator on multi-center trials within NIAID’s AIDS Clinical Trials group, and on R01 grants from NIDA. He has served on NIH study sections, CDC consensus panels, and committees within the ACTG, the NYS DOH AIDS Institute, and the NYC DOMH. Dr. Perlman’s earlier work focused on studies of the epidemiology of tuberculosis among drug users, and on health care delivery models and behavioral and structural interventions to facilitate adherence to the TB and HIV/TB care continuum. Dr. Perlman’s recent work has focused on studies of barriers and facilitators of HIV and HCV testing and care among racial and ethnic minorities, high risk heterosexuals, and people who use drugs, and more broadly on studies of strategies to improve HIV and HIV/HCV care continua and prevention programming for these populations.
Projects
Principal Investigator, Hepatitis Care Coordination in Methadone Treatment. Completed
Publications

Recent

Oxman JM, Bourne M, Perlman DC, Sells N (2026).
Myocarditis following invasive Group A Streptococcus infection: Important differential diagnostic distinctions
Case Reports in Infectious Diseases, 5349221. doi: PMC13053290.

Perlman DC, Vigneault A (2026).
Epidemics and social metabolism nature, capitalism, and rifts
Monthly Review-An Independent Socialist Magazine, 77 (8), 20-46. doi: 10.14452/MR-077-08-2026-01_2.

Friedman SR, Walters SM, Jordan AE, Perlman DC, Nikolopoulos GK, Mateu-Gelabert P, Rossi D, Eisenberg-Guyot J (2025).
Dialectical processes of health framework as an alternative to social determinants of health framework
American Journal of Public Health, 115 (11), 1868-1876. doi: 10.2105/AJPH.2025.308239. PMCID: PMC12510083.

Behrends CN, Des Jarlais DC, Luhur W, Lu X, Corry GJ, Glick SN, Kapadia SN, Perlman DC, Schackman BR (2025).
On-site health service delivery models at syringe services programs in the United States: Results of a national cross-sectional survey
Drug and Alcohol Dependence Reports, 16, 100355. doi: 10.1016/j.dadr.2025.100355. PMCID: PMC12273473.

Austin EJ, Briggs ES, Corcorran MA, Chen J, Cotta N, Behrends CN, Prohaska SM, Lakosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN (2025).
“New normal:” Opportunities and challenges faced by syringe service programs following the effects of the COVID-19 pandemic
Substance Use and Misuse, 60 (5), 669-676. doi: 10.1080/10826084.2024.2447411. PMCID: PMC11870795.

Dr. Perlman's MyBibliography Profile
Selected Press
Look to the States to Lead on Public Health
David Perlman co-authored an OpEd recommending that individual states to protect the health of its citizens by joining the Governors Public Health Alliance or other evidence-based health organizations.